HIGH RISK CLL

Clinical trials for HIGH RISK CLL explained in plain language.

Never miss a new study

Get alerted when new HIGH RISK CLL trials appear

Sign up with your email to follow new studies for HIGH RISK CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Doctors test 'Stop-and-Go' drug strategy to control tough leukemia

Disease control Ongoing

This study is testing a personalized treatment plan for young adults with a hard-to-treat form of chronic lymphocytic leukemia (CLL). All participants start with a two-drug combination. Doctors then check for tiny amounts of leftover cancer cells and adjust the treatment plan. So…

Matched conditions: HIGH RISK CLL

Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

HIGH RISK CLL

Get alerted when new HIGH RISK CLL trials appear

Doctors test 'Stop-and-Go' drug strategy to control tough leukemia